ALKERMES | ALKS - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
AbbVie USD 42.1B 1.19B 2026-03
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
ALKERMES USD 662.09M 62.59M 2026-06
Amgen USD 24.96B 534M 2026-03
Biogen USD 3.92B 918.2M 2026-06
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Coherus Biosciences USD 140.39M 231.91M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
Heron Therapeutics USD 90.52M 5.58M 2026-03
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
J&J USD 54.9B 2.82B 2026-06
Malin Corporation EUR 1000K 500K 2024-12
Merck USD 26.94B 1.38B 2026-03
Minerva Neurosciences USD 2.29M 381K 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Otsuka Holdings JPY 738.96B 52.85B 2026-06
Ovoca Bio EUR 186K 2.26M 2025-06
Pfizer USD 34.35B 2.64B 2026-03
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03